title: Parapoxviruses: potential alternative vectors for directing the immune response in permissive and non-permissive hosts.
abstract: Parapoxvirus (PPV) represents a genus of the poxviridae, and particularly PPV ovis (Orf virus, OV) seems to offer several potential advantages for the use of vector vaccine. Therefore, we started to investigate the genome of the highly attenuated OV strain D1701, which was only poorly characterised until now. Due to recombination of non-homologous sequences, part of the right hand end of the D1701 genome was duplicated and translocated to the opposite end of the genome. As a consequence gene deletion had occurred and the inverted terminal repeat region is increased. Results are described to identify viral genes, which are non-essential for virus replication and potentially influence viral pathogenesis, virulence, and host immunity. In more detail, we analysed the expression and functional activity of the OV-specific vascular endothelial growth factor (VEGF) gene homologue. Finally the construction and production of a D1701 mutant lacking the VEGF gene homologue is reported.
authors.affiliation: Federal Research Centre for Virus Diseases of Animals, Institute for Vaccines, Tübingen, Germany. achim.rziha@tue.bfav.de
authors.forename: H J
authors.initials: HJ
authors.lastname: Rziha
authors.forename: M
authors.initials: M
authors.lastname: Henkel
authors.forename: R
authors.initials: R
authors.lastname: Cottone
authors.forename: M
authors.initials: M
authors.lastname: Meyer
authors.forename: C
authors.initials: C
authors.lastname: Dehio
authors.forename: M
authors.initials: M
authors.lastname: Büttner
mesh_terms: D000818:Animals; D001709:Biotechnology; D002874:Chromosome Mapping; D016228:Endothelial Growth Factors / Q000235:genetics; D017353:Gene Deletion; D005822:Genetic Vectors; D016679:Genome, Viral; D006801:Humans; D008222:Lymphokines / Q000235:genetics; D009923:Orf virus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D018157:Parapoxvirus / Q000235:genetics* / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D014614:Vaccines, Synthetic; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors